PROGNOSTIC MARKERS OF ACTIVITY AND DAMAGE IN RHEUMATOID ARTHRITIS: WHY CLINICAL TRIALS AND INCEPTION COHORT STUDIES INDICATE MORE FAVOURABLE OUTCOMES THAN STUDIES OF PATIENTS WITH ESTABLISHED DISEASE
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.